The benefits of ready-to-use single-use systems are well documented and include:

Scalable—BPC systems are well suited for use from benchtop to production scale processes.
Ready integration—BPC components work well in all steps in the production of therapeutic biologics and vaccines.

Operational—Help reduce the risk of cross-contamination. Additionally, the elimination of cleaning-in-place and sterilization-in-place (CIP/SIP) systems reduces setup, maintenance, and validation times, enabling increased output.

Economic—Help reduce capital investment and labor costs, leading to a reduction in cost of goods sold.
Strategic—Enable shorter time to market and reduction of risk earlier in the product development cycle, due to lower investment.